Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial

✍ Scribed by Mitin, Timur (author);Hunt, Daniel (author);Shipley, William U. (author);Kaufman, Donald S. (author);Uzzo, Robert (author);Wu, Chin Lee (author);Buyyounouski, Mark K. (author);Sandler, Howard (author);Zietman, Anthony L. (author)

• Book ID: 120523605
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 351 KB
• Volume: 14
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(13)70255-9